annual CFO:
$11.86B+$1.52B(+14.65%)Summary
- As of today (May 29, 2025), AZN annual cash flow from operations is $11.86 billion, with the most recent change of +$1.52 billion (+14.65%) on December 31, 2024.
- During the last 3 years, AZN annual CFO has risen by +$5.90 billion (+98.91%).
- AZN annual CFO is now at all-time high.
Performance
AZN Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$3.71B+$806.00M(+27.73%)Summary
- As of today (May 29, 2025), AZN quarterly cash flow from operations is $3.71 billion, with the most recent change of +$806.00 million (+27.73%) on March 31, 2025.
- Over the past year, AZN quarterly CFO has increased by +$1.23 billion (+49.36%).
- AZN quarterly CFO is now -9.04% below its all-time high of $4.08 billion, reached on December 31, 2009.
Performance
AZN quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$13.09B+$1.23B(+10.34%)Summary
- As of today (May 29, 2025), AZN TTM cash flow from operations is $13.09 billion, with the most recent change of +$1.23 billion (+10.34%) on March 31, 2025.
- Over the past year, AZN TTM CFO has increased by +$3.39 billion (+34.96%).
- AZN TTM CFO is now at all-time high.
Performance
AZN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AZN Cash from operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +14.7% | +49.4% | +35.0% |
3 y3 years | +98.9% | +14.9% | +80.3% |
5 y5 years | +299.5% | +2571.2% | +274.5% |
AZN Cash from operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +98.9% | at high | +197.5% | at high | +80.3% |
5 y | 5-year | at high | +299.5% | at high | +2571.2% | at high | +274.5% |
alltime | all time | at high | +5650.2% | -9.0% | +476.2% | at high | +2812.2% |
AZN Cash from operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $3.71B(+27.7%) | $13.09B(+10.3%) |
Dec 2024 | $11.86B(+14.7%) | $2.91B(-14.1%) | $11.86B(+4.6%) |
Sep 2024 | - | $3.38B(+9.7%) | $11.33B(+2.4%) |
Jun 2024 | - | $3.08B(+24.1%) | $11.06B(+14.1%) |
Mar 2024 | - | $2.49B(+4.5%) | $9.70B(-6.3%) |
Dec 2023 | $10.35B(+5.5%) | $2.38B(-23.6%) | $10.35B(-0.2%) |
Sep 2023 | - | $3.11B(+81.3%) | $10.36B(+1.8%) |
Jun 2023 | - | $1.72B(-45.2%) | $10.18B(+4.8%) |
Mar 2023 | - | $3.13B(+30.7%) | $9.71B(-1.0%) |
Dec 2022 | $9.81B(+64.5%) | $2.40B(-18.2%) | $9.81B(+11.1%) |
Sep 2022 | - | $2.93B(+134.8%) | $8.83B(+15.9%) |
Jun 2022 | - | $1.25B(-61.4%) | $7.62B(+4.9%) |
Mar 2022 | - | $3.23B(+127.9%) | $7.26B(+21.8%) |
Dec 2021 | $5.96B(+24.3%) | $1.42B(-17.5%) | $5.96B(-6.0%) |
Sep 2021 | - | $1.72B(+92.7%) | $6.34B(-1.6%) |
Jun 2021 | - | $892.00M(-53.9%) | $6.45B(-2.2%) |
Mar 2021 | - | $1.93B(+7.6%) | $6.59B(+37.4%) |
Dec 2020 | $4.80B(+61.6%) | $1.80B(-1.3%) | $4.80B(+9.7%) |
Sep 2020 | - | $1.82B(+75.2%) | $4.38B(+19.7%) |
Jun 2020 | - | $1.04B(+648.2%) | $3.66B(+4.6%) |
Mar 2020 | - | $139.00M(-89.9%) | $3.50B(+17.7%) |
Dec 2019 | $2.97B(+13.4%) | $1.38B(+24.7%) | $2.97B(-22.2%) |
Sep 2019 | - | $1.10B(+25.6%) | $3.82B(+19.9%) |
Jun 2019 | - | $878.00M(-326.9%) | $3.18B(+34.3%) |
Mar 2019 | - | -$387.00M(-117.4%) | $2.37B(-9.4%) |
Dec 2018 | $2.62B(-26.8%) | $2.22B(+374.2%) | $2.62B(+88.2%) |
Sep 2018 | - | $469.00M(+621.5%) | $1.39B(-56.1%) |
Jun 2018 | - | $65.00M(-146.4%) | $3.17B(-5.5%) |
Mar 2018 | - | -$140.00M(-114.0%) | $3.35B(-6.4%) |
Dec 2017 | $3.58B(-13.7%) | $997.00M(-55.6%) | $3.58B(-21.2%) |
Sep 2017 | - | $2.24B(+797.2%) | $4.54B(+46.1%) |
Jun 2017 | - | $250.00M(+184.1%) | $3.11B(+2.3%) |
Mar 2017 | - | $88.00M(-95.5%) | $3.04B(-26.7%) |
Dec 2016 | $4.14B(+24.7%) | $1.96B(+141.7%) | $4.14B(+50.4%) |
Sep 2016 | - | $811.00M(+348.1%) | $2.76B(-25.3%) |
Jun 2016 | - | $181.00M(-84.8%) | $3.69B(-19.6%) |
Mar 2016 | - | $1.19B(+108.9%) | $4.59B(+38.1%) |
Dec 2015 | $3.32B(-52.9%) | $571.00M(-67.3%) | $3.32B(-27.7%) |
Sep 2015 | - | $1.75B(+61.6%) | $4.59B(-4.3%) |
Jun 2015 | - | $1.08B(-1600.0%) | $4.80B(-17.2%) |
Mar 2015 | - | -$72.00M(-103.9%) | $5.80B(-17.8%) |
Dec 2014 | $7.06B(-4.6%) | $1.84B(-5.5%) | $7.06B(-8.3%) |
Sep 2014 | - | $1.95B(-6.2%) | $7.69B(+12.1%) |
Jun 2014 | - | $2.08B(+75.1%) | $6.86B(+7.4%) |
Mar 2014 | - | $1.19B(-52.1%) | $6.39B(-13.7%) |
Dec 2013 | $7.40B(+6.5%) | $2.48B(+121.6%) | $7.40B(-4.8%) |
Sep 2013 | - | $1.12B(-30.4%) | $7.77B(-2.4%) |
Jun 2013 | - | $1.61B(-26.9%) | $7.96B(+4.7%) |
Mar 2013 | - | $2.20B(-22.8%) | $7.61B(+9.5%) |
Dec 2012 | $6.95B(-11.2%) | $2.85B(+117.6%) | $6.95B(-3.1%) |
Sep 2012 | - | $1.31B(+4.6%) | $7.17B(-7.9%) |
Jun 2012 | - | $1.25B(-18.8%) | $7.78B(+4.2%) |
Mar 2012 | - | $1.54B(-49.8%) | $7.47B(-4.5%) |
Dec 2011 | $7.82B | $3.07B(+59.6%) | $7.82B(-5.9%) |
Sep 2011 | - | $1.92B(+104.8%) | $8.31B(-4.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2011 | - | $939.00M(-50.3%) | $8.74B(-19.3%) |
Mar 2011 | - | $1.89B(-46.9%) | $10.83B(+1.4%) |
Dec 2010 | $10.68B(-9.0%) | $3.56B(+51.3%) | $10.68B(-4.7%) |
Sep 2010 | - | $2.35B(-22.3%) | $11.20B(+0.3%) |
Jun 2010 | - | $3.03B(+74.1%) | $11.17B(-0.7%) |
Mar 2010 | - | $1.74B(-57.4%) | $11.25B(-4.2%) |
Dec 2009 | $11.74B(+34.3%) | $4.08B(+75.7%) | $11.74B(+12.4%) |
Sep 2009 | - | $2.32B(-25.2%) | $10.45B(+6.8%) |
Jun 2009 | - | $3.11B(+39.5%) | $9.78B(+14.1%) |
Mar 2009 | - | $2.23B(-20.2%) | $8.58B(-1.9%) |
Dec 2008 | $8.74B(+16.4%) | $2.79B(+68.2%) | $8.74B(-2.3%) |
Sep 2008 | - | $1.66B(-12.7%) | $8.95B(+3.8%) |
Jun 2008 | - | $1.90B(-20.5%) | $8.62B(+11.7%) |
Mar 2008 | - | $2.39B(-20.2%) | $7.71B(+2.7%) |
Dec 2007 | $7.51B(-2.4%) | $3.00B(+125.8%) | $7.51B(+12.6%) |
Sep 2007 | - | $1.33B(+33.2%) | $6.67B(-10.5%) |
Jun 2007 | - | $997.00M(-54.4%) | $7.46B(-10.9%) |
Mar 2007 | - | $2.19B(+1.3%) | $8.37B(+8.8%) |
Dec 2006 | $7.69B(+14.1%) | $2.16B(+2.3%) | $7.69B(+3.1%) |
Sep 2006 | - | $2.11B(+10.6%) | $7.46B(+6.4%) |
Jun 2006 | - | $1.91B(+26.3%) | $7.01B(+3.9%) |
Mar 2006 | - | $1.51B(-21.6%) | $6.75B(+0.0%) |
Dec 2005 | $6.74B(+40.0%) | $1.93B(+16.2%) | $6.74B(-1.3%) |
Sep 2005 | - | $1.66B(+0.9%) | $6.83B(+8.7%) |
Jun 2005 | - | $1.65B(+9.0%) | $6.29B(+24.7%) |
Mar 2005 | - | $1.51B(-25.2%) | $5.04B(+4.7%) |
Dec 2004 | $4.82B(+43.0%) | $2.02B(+80.8%) | $4.82B(+59.4%) |
Sep 2004 | - | $1.12B(+178.3%) | $3.02B(+2.3%) |
Jun 2004 | - | $401.00M(-68.7%) | $2.95B(-15.3%) |
Mar 2004 | - | $1.28B(+474.9%) | $3.49B(+3.5%) |
Dec 2003 | $3.37B(-30.3%) | $223.00M(-78.7%) | $3.37B(-14.2%) |
Sep 2003 | - | $1.05B(+12.1%) | $3.93B(-7.6%) |
Jun 2003 | - | $933.92M(-19.8%) | $4.25B(+2.3%) |
Mar 2003 | - | $1.16B(+49.0%) | $4.15B(-14.1%) |
Dec 2002 | $4.83B(+54.6%) | $780.92M(-43.0%) | $4.83B(+3.1%) |
Sep 2002 | - | $1.37B(+63.7%) | $4.69B(+11.3%) |
Jun 2002 | - | $837.00M(-54.6%) | $4.21B(+13.0%) |
Mar 2002 | - | $1.84B(+189.6%) | $3.73B(+19.3%) |
Dec 2001 | $3.13B(+33.8%) | $637.00M(-28.7%) | $3.13B(+108.1%) |
Sep 2001 | - | $894.00M(+153.9%) | $1.50B(-42.6%) |
Jun 2001 | - | $352.04M(-71.7%) | $2.62B(-16.3%) |
Mar 2001 | - | $1.24B(-225.9%) | $3.13B(+34.0%) |
Dec 2000 | $2.34B(+9.9%) | -$986.91M(-149.1%) | $2.34B(-29.7%) |
Sep 2000 | - | $2.01B(+133.1%) | $3.32B(+153.2%) |
Jun 2000 | - | $862.75M(+92.0%) | $1.31B(+192.0%) |
Mar 2000 | - | $449.42M | $449.42M |
Dec 1999 | $2.13B(-37.9%) | - | - |
Dec 1998 | $3.42B(+358.0%) | - | - |
Dec 1997 | $747.21M(-5.1%) | - | - |
Dec 1996 | $787.75M(+34.5%) | - | - |
Dec 1995 | $585.64M(-6.4%) | - | - |
Dec 1994 | $625.36M(-11.4%) | - | - |
Dec 1993 | $705.58M(+242.1%) | - | - |
Dec 1992 | $206.27M(-59.2%) | - | - |
Dec 1991 | $505.22M(-37.3%) | - | - |
Dec 1990 | $806.30M | - | - |
FAQ
- What is AstraZeneca annual cash flow from operations?
- What is the all time high annual CFO for AstraZeneca?
- What is AstraZeneca annual CFO year-on-year change?
- What is AstraZeneca quarterly cash flow from operations?
- What is the all time high quarterly CFO for AstraZeneca?
- What is AstraZeneca quarterly CFO year-on-year change?
- What is AstraZeneca TTM cash flow from operations?
- What is the all time high TTM CFO for AstraZeneca?
- What is AstraZeneca TTM CFO year-on-year change?
What is AstraZeneca annual cash flow from operations?
The current annual CFO of AZN is $11.86B
What is the all time high annual CFO for AstraZeneca?
AstraZeneca all-time high annual cash flow from operations is $11.86B
What is AstraZeneca annual CFO year-on-year change?
Over the past year, AZN annual cash flow from operations has changed by +$1.52B (+14.65%)
What is AstraZeneca quarterly cash flow from operations?
The current quarterly CFO of AZN is $3.71B
What is the all time high quarterly CFO for AstraZeneca?
AstraZeneca all-time high quarterly cash flow from operations is $4.08B
What is AstraZeneca quarterly CFO year-on-year change?
Over the past year, AZN quarterly cash flow from operations has changed by +$1.23B (+49.36%)
What is AstraZeneca TTM cash flow from operations?
The current TTM CFO of AZN is $13.09B
What is the all time high TTM CFO for AstraZeneca?
AstraZeneca all-time high TTM cash flow from operations is $13.09B
What is AstraZeneca TTM CFO year-on-year change?
Over the past year, AZN TTM cash flow from operations has changed by +$3.39B (+34.96%)